Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
V Strand(University of Leeds), Paul Emery(University of Leeds), Anil John(University of Benin), Sarika Ogale(University of Leeds), Jenny Devenport(University of Leeds), Gerd‐Rüdiger Burmester(University of Leeds)
Cited by 106
Related Papers
Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
|Annals of Tropical Medicine and Parasitology|2002|40
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
|Annals of Tropical Medicine and Parasitology|2000|39